A carregar...
Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1
BACKGROUND: Tamoxifen provides a 50% reduction in the incidence of breast cancer (BC) among high-risk women, yet many do not adhere to the five-year course of therapy. Using the prospective double-blind National Surgical Adjuvant Breast and Bowel Project P-1 study, we evaluated whether participant-r...
Na minha lista:
| Publicado no: | J Natl Cancer Inst |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4675829/ https://ncbi.nlm.nih.gov/pubmed/26615179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djv365 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|